Aktiespot

Galderma Group AG aksje

GALDZ.XC

Stengt
CHF163.25-0.30 (-0.18%)
Laster graf...

Galderma Group AG

Åpning163.45
Høy164.95
Lav161.45
Volum40k
P/E80.42
Markedsverdi38.29B
52-ukers høy171.85
52-ukers lav107.70
Gj.sn. volum117.33k
UtbytteN/A
Beta-0.05
EPS2.03

Om Galderma Group AG aksje

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Selskapsinformasjon

Børs: Cboe UK (CXE)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
Zählerweg 10
6300 Zug, Switzerland
Telefon: + 41 58 455 85 92

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål

Andre ser også på: